A Boban Blagaic
Overview
Explore the profile of A Boban Blagaic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vukusic D, Zenko Sever A, Sever M, Drmic D, Milavic M, Sikiric S, et al.
J Physiol Pharmacol
. 2024 Apr;
75(1).
PMID: 38583442
Using duodenocolic fistula in rats, this study attempts to highlight the particular cytoprotection aspects of the healing of fistulas and therapy potential of the stable gastric pentadecapeptide BPC 157, a...
2.
Bilic Z, Gojkovic S, Kalogjera L, Krezic I, Malekinusic D, Knezevic M, et al.
J Physiol Pharmacol
. 2022 Apr;
72(6).
PMID: 35485358
Surgically perforated stomach (since direct injury in rats until persisting defect and huge adhesions (day 1, day 7)) fairly represent an unresolved cytoprotection issue, and thereby, we focused resolving of...
3.
Petrovic I, Dobric I, Drmic D, Sever M, Klicek R, Radic B, et al.
J Physiol Pharmacol
. 2011 Dec;
62(5):527-34.
PMID: 22204800
Possibly, acute esophagitis and pancreatitis cause each other, and we focused on sphincteric failure as the common causative key able to induce either esophagitis and acute pancreatitis or both of...
4.
Ilic S, Drmic D, Zarkovic K, Kolenc D, coric M, Brcic L, et al.
J Physiol Pharmacol
. 2010 May;
61(2):241-50.
PMID: 20436226
We focused on stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419, an anti-ulcer peptide efficient in inflammatory bowel disease trials (PL 14736), no toxicity reported) because of its hepatoprotective effects....
5.
Boban Blagaic A, Turcic P, Blagaic V, Dubovecak M, Jelovac N, Zemba M, et al.
J Physiol Pharmacol
. 2010 Apr;
60 Suppl 7:177-81.
PMID: 20388962
Previously, the gastric pentadecapeptide BPC 157, (PL 14736, Pliva) has been shown to have several beneficial effects, it exert gastroprotective, anti-inflammatory actions, stimulates would healing and has therapeutic value in...
6.
Bilic M, Bumber Z, Boban Blagaic A, Batelja L, Seiwerth S, Sikiric P
Burns
. 2005 Mar;
31(3):310-5.
PMID: 15774286
The stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV; mol. wt. 1419), which is at present in phase II clinical trials for the treatment of inflammatory bowel disease, has been shown to...